AI Assistant
Blog
Pricing
Log In
Sign Up
A phase II dose-ranging study of mirabegron in patients with overactive bladder
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.